Arhalofenate Completed Phase 2 Trials for Gouty Arthritis Treatment

Indications	Status	Purpose	Phase
DBCOND0052747 (Gouty Arthritis)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02063997	Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients	Allopurinol (DB00437) Arhalofenate (DB11811) Colchicine (DB01394)
NCT01399008	Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients	Allopurinol (DB00437) Arhalofenate (DB11811) Colchicine (DB01394)